The role of theophylline in asthma management

Current Opinion in Pulmonary Medicine

Volumn 5, Issue 2, 1999, Pages 88-92

  Kips, Johan C ^a   Peleman, Renaat A ^a   Pauwels, Romain A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; THEOPHYLLINE;

ASTHMA; DRUG COMBINATION; HUMAN; REVIEW;

ASTHMA; BRONCHODILATOR AGENTS; DRUG THERAPY, COMBINATION; HUMANS; THEOPHYLLINE;

EID: 0033085827     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199903000-00002     Document Type: Article

References (55)

1. Rabe KF, Dent G: Theophylline. In Asthma. Edited by Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ. Philadelphia: Lippincott-Raven Publishers; 1997:1535-1554.
2. Magnussen H, Jörres R, Hartmann V: Bronchodilator effect of theophylline preparations and aerosol fenoterol in stable asthma. Chest 1986, 90:722-725.
3. Magnussen H, Reuss G, Jörres R: Theophylline has a dose-related effect on the airway response to inhaled histamine and methacholine in asthmatics. Am Rev Respir Dis 1987, 136:1163-1167.
4. Cartier A, Lemire I, Archeveque J, Ghezzo H, Martin RR, Malo J-L: Theophylline partially inhibits bronchoconstriction caused by inhaled histamine in subjects with asthma. J Allergy Clin Immunol 1986, 77:570-575.
5. Dutoit JI, Salome CM, Woolcock AJ: Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not. Am Rev Respir Dis 1987, 136:1174-1178.
6. Moxham J: Aminophylline and the respiratory muscles: an alternative view. Clin Chest Med 1998, 2:325-340.
7. Barnes PJ, Pauwels RA: Theophylline in the management of asthma: time for reappraisal? Eur Respir J 1994, 7:579-591.
8. Kraft M, Torvik JA, Trudeau JB, Wenzel SE, Martin RJ: Theophylline: potential antiinflammatory effects in nocturnal asthma. J Allergy Clin Immunol 1996, 97:1242-1246.
9. Ward AJM, McKennif M, Evans JM, Page CP, Costello JF: Theophylline: an immunomodulatory role in asthma? Am Rev Respir Dis 1993, 147:518-523.
10. Finnerty JP, Lee C, Wilson S, Madden J, Djukanovic R, Holgate ST: Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group study. Eur Respir J 1996, 9:1672-1677.
11. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ: Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995, 151:1907-1914.
12. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J: Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994, 343:1006-1008.
13. Kelloway JS, Wyatt RA, Adlis SA: Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994, 154:1349-1352.
14. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention, Washington, DC: National Heart, Lung, and Blood Institute; 1995. (Publication no. 95-3659.)
15. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH, Holgate ST: State of the art: mucosal inflammation in asthma. Am Rev Respir Dis 1990, 142:434-457.
16. Redington AE, Howarth PH: Airway wall remodelling in asthma. Thorax 1997, 52:310-312.
17. Paré PD, Bai TR: The consequences of chronic allergic inflammation. Thorax 1995, 50:328-332.
18. Weinberger M: The pharmacology and therapeutic use of theophylline. J Allergy Clin Immunol 1984, 73:525-540.
19. Hambleton G, Weinberger M, Taylor J: Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma: a collaborative study. Lancet 1977, 1:381-385.
20. Koeter GH, Kraan J, Boorsma M, Jonkman JHG, Van Der Mark TW: Effect of theophylline and enprophylline on bronchial hyperresponsiveness. Thorax 1989, 44:1022-1026.
21. Page CP, Cotter T, Kilfeather S, Sullivan P, Spina D, Costello JF: Effect of chronic theophylline treatment on the methacholine dose-response curve in allergic asthmatic subjects. Eur Respir J 1998, 12:24-29. Well-conducted, detailed study showing that the effect of theophylline on airway hypersensitivity and hyperreactivity is little different from placebo.
22. Woolcock AJ, Salome CM, Yan K: The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis 1984, 130:71-75.
23. Rabe KF, Dent G: Theophylline and airway inflammation. Clin Exp Allergy 1998, 28(suppl 3):35-41.
24. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF, Dutch CNSLD Study Group: Effects of 22 months treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 1992, 146:547-554.
25. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991, 325:388-392.
26. Bel EH, Timmers MC, Zwinderman AH, Dijkman JH, Sterk PJ: The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis 1991, 143:109-113.
27. Overbeek SE, Rijnbeek PR, Vons C, Mulder PG, Hoogsteden HC, Bogaard JM: Effects of fluticasone propionate on methacholine dose-response curves in nonsmoking atopic asthmatics. Eur Respir J 1996, 9:2256-2262.
28. Jeffery PK, Godfrey RW, Ädelroth E, Nelson F, Rogers A, Johansson SA: Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992, 145:890-899.
29. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma. J Allergy Clin Immunol 1992, 90:32-42.
30. Djukanovic R, Wilson JW, Britten JM, Wilson SJ, Walls AF, Roche WF, Howarth PH, Holgate ST: Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992, 145:669-674.
31. Olivieri D, Chetta A, Del Donno M, Bertorelli G, Casalini A, Pesci A, et al.: Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodelling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997, 155:1864-1871.
32. Reed CE, Offord KP, Nelson HS, Li JT, Tinkelman DG: Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. J Allergy Clin Immunol 1998, 101:14-23. Multicenter prospective trial comparing a 1-year treatment with a low dose of inhaled steroids (400 μg beclomethasone) to theophylline on a large number of clinical outcome measures in asthma.
33. Tinkelman DG, Reed CE, Nelson HS, Offord KP: Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993, 92:64-77.
34. Barnes PJ, Greening AP, Neville L, Timmers J, Poole GW: Single dose slow-release aminophylline at night prevents nocturnal asthma. Lancet 1982, 1:299-301.
35. Nutini S, Martini T, Righi R: Long-term treatment of asthmatic patients with salmeterol vs slow-release theophylline. Respir Med 1998, 92:683-690.
36. Muir JF, Berlin L, Georges D, French Multicentre Study Group: Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. Eur Respir J 1992, 5:1197-1200.
37. Selby C, Engleman HM, Fitzpatrick MF, Sime PM, Mackay TW, Douglas NJ: Inhaled salmeterol or oral theophylline in nocturnal asthma? Am J Respir Crit Care Med 1997, 155:104-108. An interesting study that compares salmeterol with theophylline on nocturnal asthma control and sleep quality in steroid-treated patients.
38. Greening AP, Ind PW, Northfield M, Shaw G: Added salmeterol versus high-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994, 344:219-224.
39. Woolcock A, Lundback B, Ringdal N, Jacques LA: Comparison of addition salmeterol to inhaled steroids with doubling the dose of inhaled steroids. Am J Respir Crit Care Med 1996, 153:1481-1488.
40. Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne PM, Barnes PJ, Ullman A: Effects of inhaled formoterol and budesonide on asthma exacerbations. N Engl J Med 1997, 337:1405-1411.
41. 2-agonists with a moderate to high dose of inhaled steroids versus increasing the dose of steroids has been extensively investigated. This study illustrates the clinical superiority of adding theophylline as opposed to increasing the dose of steroids in moderate to severe asthma.
42. Ukena D, Harnest U, Sakalauskas R, Magyar P, Vetter N, Steffen H, et al.: Comparison of addition of theophylline to inhaled steroid with doubling the dose of inhaled steroid in asthma. Eur Respir J 1997, 10:2754-2760. Using a similar study design to that of Evans et al. (N Engl J Med 1997, 337:1412-1418), this study illustrates the clinical superiority of adding theophylline as opposed to increasing the dose of steroids in mild to moderate asthma.
43. Nassif EG, Weinberger M, Thompson R, Huntley W: The value of theophylline in steroid-dependent asthma. N Engl J Med 1981, 304:71-75.
44. Brenner M, Berkowitz R, Marshall N, Strunk RC: Need for theophylline in severe steroid-requiring asthmatics. Clin Allergy 1988, 18:143-150.
45. Davies B, Brooks G, Devoy M: The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies. Respir Med 1998, 92:256-263.
46. Barclay J, Whiting B, Meredith PA, Addis JG: Theophylline-salbutamol interactions: bronchodilator response to salbutamol at maximally effective theophylline concentrations. Br J Clin Pharmacol 1981, 11:203-208.
47. Nelson JA, Strauss L, Skowronski M, Ciufo R, Novak R, McFadden ER: Effect of long-term salmeterol treatment on exercise-induced asthma. N Engl J Med 1998, 339:141-146.
48. Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ: Long-term effects of a long-acting β2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992, 327:1198-1203.
49. Yates DH, Sussman HS, Shaw MJ, Barnes PJ, Chung KF: Regular formoterol treatment in mild asthma. Am J Respir Crit Care Med 1995, 152:1170-1174.
50. Otto J, Gunther S, Urbanek R: The effects of theophylline on beta2-adrenoceptors on polymorphonuclear leukocytes of asthmatic children and juveniles. Eur J Pediatr 1990, 149:661-664.
51. Mak JC, Nishikawa M, Shirasaki H, Miyasayasu K, Barnes PJ: Protective effect of a glucocorticoid on down-regulation of pulmonary β2-adrenergic receptors in vivo. J Clin Invest 1995, 96:99-106.
52. Yates DH, Kharitonov SA, Barnes PJ: An inhaled glucocorticoid does not prevent tolerance to the bronchprotective effect of a long-acting inhaled β2-agonist. Am J Respir Crit Care Med 1996, 154:1604-1607.
53. Cheung D, Wever AMJ, deGoeij JA, de Graaf CS, Steen H, Sterk PJ: Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo. Ann J Respir Crit Care Med 1998, 158:792-798. In non-steroid-treated patients with mild asthma, concomitant treatment with theophylline does not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
54. Meltzer EO, Orgel A, Ellis EF, Eigen HN, Hemstreet MPB: Long-tem comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma. J Allergy Clin Immunol 1992, 90:2-11.
55. Rivington RN, Boulet LP, Coté J, Kreisman H, Small DI, Alexander M, et al.: Efficacy of Uniphyl®, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med 1995, 151:325-332.